Medical | Page 233 of 472 | SpiritIndia.com

Health :: OneWorld Health selects Odyssey Research for phase 4 study in India

The Institute for OneWorld Health, a US-based non-profit pharmaceutical company that develops drugs for people with neglected diseases in the developing world, today announced the selection of Odyssey Research, a Bismarck, North Dakota-based clinical trial management organization (TMO) with offices in New Delhi, India, to support its upcoming Phase 4 pharmacovigilance and access study of Paromomycin Intramuscular (IM) Injection for the treatment of visceral leishmaniasis (VL) in India.

Constipation :: MiraLax switches from prescription to over-the-counter status

Schering-Plough Corporation (NYSE: SGP) announced that prescription-strength MiraLAX? (polyethylene glycol 3350) is now available as an over-the-counter (OTC) treatment for occasional constipation.

Cancer :: Natural mechanism for immune suppression paves way for cancer trials

A natural mechanism pirated by tumors and HIV to evade the immune response is opening the door to better treatment for these conditions, researchers say.

Stem Cell :: CNS Foundation grantee Dr. Evan Snyder repays special-needs community with stem cell publication

The CNS Foundation welcomes the publication by CNS grantee Dr. Evan Snyder of experimental results that extend the promise of stem cell therapies to degenerative brain diseases of childhood.

Health Care :: Adoption of health information technology will lead to higher standard of quality care

The benefits of full-scale adoption of health information technology (HIT) will be significant, leading to a higher standard of quality in the U.S. health care system, Lynne M. Kirk, MD, FACP, president of the American College of Physicians (ACP), today told a hearing of the Subcommittee on Regulations, Healthcare and Trade of the House Committee on Small Business.

Schizophrenia :: Columbia announces $9.2M expansion of Lieber Center for Schizophrenia Research

Columbia University Medical Center announces today the expansion of its Lieber Center for Schizophrenia Research and the launch of a new comprehensive psychiatric care clinic at its E. 60th Street location, all made possible through a $9.2 million gift from Stephen and Constance Lieber and the Essel Foundation.

Twins :: Conjoined Dogaru Twins to be separated in Rainbow Babies & Children’s Hospital

Anastasia and Tatiana are 3-year-old conjoined twins that a multidisciplinary team of Rainbow surgical specialists will be evaluating and attempting to separate over the next several months.

Filariasis :: LSTM to lead multi million dollar fight against filariasis

The Liverpool School of Tropical Medicine has received a $23 million grant from the Bill & Melinda Gates Foundation to help victims of human filariasis — a worm infection which causes some of the world?s most debilitating and distressing diseases.

Herbal :: Think herbal supplements are safe ?

People are mixing supplements, herbs and over-the-counter medications and prescription drugs to cure themselves of ills, unaware that they could be making themselves sicker, says George Grossberg, M.D., director of the division of geriatric psychiatry at Saint Louis University.

Prostate Cancer :: Biopsy may underestimate prostate cancer in obese and overweight men

Obese and overweight men who are diagnosed with prostate cancer by biopsy are more likely than healthy weight men to actually have a more aggressive case of the disease than the biopsy results would indicate, according to a study led by a Duke University Medical Center researcher.